The sequential administration of nicotinamide and STZ effectively replicates key aspects of T2DM, including β-cell dysfunction, insulin resistance, hyperglycemia, and dyslipidemia, resembling the progressive nature of the disease in humans [2]. Here, INS is linked to Hyperglycemia.